1. Dutta A, Mungle T, Chowdhury N, Banerjee P, Gehani A, Sen S, Mallath M, Roy P, Krishnan S, Ganguly S, Banerjee S, Roy M, Saha V. Characteristics and outcomes of gallbladder cancer patients at the Tata Medical Center, Kolkata 2017-2019. Cancer Med. 2023 Apr;12(8):9293-9302. doi: 10.1002/cam4.5677. Epub 2023 Feb 13. PMID: 36779618; PMCID: PMC10166897.

2. Mungle T, Mahadevan A, Das P, Mehta AK, Gogoi MP, Jana B, Ghara N, Ghosh D, Saha V, Krishnan S. Hybrid Email and Outpatient Clinics to Optimize Maintenance Therapy in Acute Lymphoblastic Leukemia. J Pediatr Hematol Oncol. 2024 Jan 1;46(1):39-45. doi: 10.1097/MPH.0000000000002796. Epub 2023 Dec 12. PMID: 38096154; PMCID: PMC10756697.

3. Sidhu J, Chakraborty A, Das P, Gogoi MP, Dey T, Steffen FD, Basu S, Ganguli D, Ghosh D, Ghara N, Kundu S, Kar A, Bornhauser B, Bourquin JP, Saha V, Krishnan S. Delayed Intensification Including Venetoclax and Bortezomib Prolongs Survival in Very High Risk Acute Lymphoblastic Leukaemia. The American Society of Hematology. https://doi.org/10.1182/blood-2023-185989

4. Sidhu J, Steffen FD, Jimenez IA, Huang Y, Rauwolf KK, Chakraborty A, Krishnan S, Saha V, Bornhauser B, Bourquin JP. Phenotypic Drug Response Profiling Identifies Asparaginase-Based Synergistic Combinations for Very High Risk Acute Lymphoblastic Leukaemia. The American Society of Hematology. https://doi.org/10.1182/blood-2023-172885

5. Sidhu J, Gogoi MP, Krishnan S, Saha V. Relapsed Acute Lymphoblastic Leukemia. Indian Journal of Pediatrics. https://doi.org/10.1007/s12098-023-04635-4

6. Bhattacharya S, Saha V. How to write a research grant proposal. Indian Journal of Medical Microbiology.

7. Moreira DC, Metzger ML, Antillón-Klussmann F, González-Ramella O, Gao Y, Bazzeh F, Middlekauff J, Fox Irwin L, Gonzalez ML, Chantada G, Barr RD, Garrington T, Hastings C, Kutluk T, Saab R, Khan MS, Saha V, Rodríguez-Galindo C, Friedrich P. Development of EPAT: An assessment tool for pediatric hematology/oncology training programs. Cancer. 2023 Nov 1;129(21):3448-3456. doi: 10.1002/cncr.34946. Epub 2023 Jul 7. PMID: 37417913.

8. Berger A, Rennie S, Aijaz J, Johnson LM, Antillon F, Roberts MC, Chitsike I, Kambugu J, Saha V, Bhakta N, Davis AM, Alexander TB. The role of relative advantage for development of sequencing-based diagnostics for pediatric cancer in low- and middle-income countries. Cancer. 2023 Oct 16. doi: 10.1002/cncr.35065. Epub ahead of print. PMID: 37843081.

9. Krishnan S, Mahadevan A, Mungle T, Gogoi MP, Saha V. Maintenance Treatment in Acute Lymphoblastic Leukemia: A Clinical Primer. Indian J Pediatr. 2024 Jan;91(1):47-58. doi: 10.1007/s12098-023-04687-6. Epub 2023 Jul 26. PMID: 37493925.

10. Sinha N, Zahra T, Gahane AY, Rout B, Bhattacharya A, Basu S, Chakrabarti A, Thakur AK. Protein reservoirs of seeds are amyloid composites employed differentially for germination and seedling emergence. Plant J. 2023 Oct;116(2):329-346. doi: 10.1111/tpj.16429. Epub 2023 Sep 7. PMID: 37675599.

1. Das N, Banavali S, Bakhshi S, Trehan A, Radhakrishnan V, Seth R, Arora B, Narula G, Sinha S, Roy P, Gogoi MP, Chatterjee S, Abraham B, Das P, Saha V, Krishnan S. Protocol for ICiCLe-ALL-14 (InPOG-ALL-15-01): a prospective, risk stratified, randomised, multicentre, open label, controlled therapeutic trial for newly diagnosed childhood acute lymphoblastic leukaemia in India. Trials. 2022 Jan 31;23(1):102. doi: 10.1186/s13063-022-06033-1. PMID: 35101099; PMCID: PMC8805436.

2. Sidhu J, Masurekar AN, Gogoi MP, Fong C, Ioannou T, Lodhi T, Parker C, Liu J, Kirkwood AA, Moorman AV, Das K, Goulden NJ, Vora A, Saha V, Krishnan S. Activity and toxicity of intramuscular 1000 iu/m2 polyethylene glycol-E. coli L-asparaginase in the UKALL 2003 and UKALL 2011 clinical trials. Br J Haematol. 2022 Jul;198(1):142-150. doi: 10.1111/bjh.18158. Epub 2022 Mar 29. PMID: 35348200; PMCID: PMC9314843.

3. Mungle T, Das N, Pal S, Gogoi MP, Das P, Ghara N, Ghosh D, Arora RS, Bhakta N, Saha V, Krishnan S. Comparative treatment costs of risk-stratified therapy for childhood acute lymphoblastic leukemia in India. Cancer Med. 2023 Feb;12(3):3499-3508. doi: 10.1002/cam4.5140. Epub 2022 Aug 15. PMID: 36812120; PMCID: PMC9939102.

4. Gallon R, Phelps R, Betts L, Hayes C, Masic D, Irving JAE, McAnulty C, Saha V, Vora A, Wimmer K, Motwani J, Macartney C, Burn J, Jackson MS, Moorman AV, Santibanez-Koref M. Detection of constitutional mismatch repair deficiency in children and adolescents with acute lymphoblastic leukemia. Leuk Lymphoma. 2023 Jan;64(1):217-220. doi: 10.1080/10428194.2022.2131412. Epub 2022 Oct 22. PMID: 36272172.

5. Locatelli F, Zugmaier G, Rizzari C, Morris JD, Gruhn B, Klingebiel T, Parasole R, Linderkamp C, Flotho C, Petit A, Micalizzi C, Zeng Y, Desai R, Kormany WN, Eckert C, Möricke A, Sartor M, Hrusak O, Peters C, Saha V, Vinti L, von Stackelberg A. Improved survival and MRD remission with blinatumomab vs. chemotherapy in children with first high-risk relapse B-ALL. Leukemia. 2023 Jan;37(1):222-225. doi: 10.1038/s41375-022-01770-3. Epub 2022 Dec 8. PMID: 36482128; PMCID: PMC9883152.

6. Bhattacharyya A, Das A, Dalvi-Mitra S, Goel G, Bhattacharya S, Chowdhury S, Saha V. Surveillance and caregiver vaccination prevent varicella outbreaks in a residential care facility for children with cancer. Pediatr Blood Cancer. 2022 May;69(5):e29631. doi: 10.1002/pbc.29631. Epub 2022 Mar 2. PMID: 35234331.

7. Saab R, Santana V, Obeid A, Devidas M, Belgaumi A, Bhakta N, Naidu P, Saha V, Sultan I, Arora RS, Mukoka L, Jeha S. Addressing the Gap in Research Methodologies Education in Pediatric Oncology in the Eastern Mediterranean Region. JCO Glob Oncol. 2023 Feb;9:e2200295. doi: 10.1200/GO.22.00295. PMID: 36780591; PMCID: PMC10166560.

1.Sidhu J, Gogoi MP, Agarwal P, Mukherjee T, Saha D, Bose P, Roy P, Phadke Y, Sonawane B, Paul P, Saha V, Krishnan S. Unsatisfactory quality of E. coli asparaginase biogenerics in India: Implications for clinical outcomes in acute lymphoblastic leukaemia. Pediatr Blood Cancer. 2021 Nov;68(11):e29046. doi: 10.1002/pbc.29046. Epub 2021 May 3. PMID: 33939263; PMCID: PMC7613163.

2. Locatelli F, Zugmaier G, Rizzari C, Morris JD, Gruhn B, Klingebiel T, Parasole R, Linderkamp C, Flotho C, Petit A, Micalizzi C, Mergen N, Mohammad A, Kormany WN, Eckert C, Möricke A, Sartor M, Hrusak O, Peters C, Saha V, Vinti L, von Stackelberg A. Effect of Blinatumomab vs Chemotherapy on Event-Free Survival Among Children With High-risk First-Relapse B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial. JAMA. 2021 Mar 2;325(9):843-854. doi: 10.1001/jama.2021.0987. PMID: 33651091; PMCID: PMC7926287.

3. Eckert C, Parker C, Moorman AV, Irving JA, Kirschner-Schwabe R, Groeneveld-Krentz S, Révész T, Hoogerbrugge P, Hancock J, Sutton R, Henze G, Chen-Santel C, Attarbaschi A, Bourquin JP, Sramkova L, Zimmermann M, Krishnan S, von Stackelberg A, Saha V. Risk factors and outcomes in children with high-risk B-cell precursor and T-cell relapsed acute lymphoblastic leukaemia: combined analysis of ALLR3 and ALL-REZ BFM 2002 clinical trials. Eur J Cancer. 2021 Jul;151:175-189. doi: 10.1016/j.ejca.2021.03.034. Epub 2021 May 16. PMID: 34010787.

4. Gupta T, Arun SR, Babu GA, Chakrabarty BK, Bhave SJ, Kumar J, Radhakrishnan V, Krishnan S, Ghara N, Arora N, Mishra DK, Parihar M. A Systematic Cytogenetic Strategy to Identify Masked Hypodiploidy in Precursor B Acute Lymphoblastic Leukemia in Low Resource Settings. Indian J Hematol Blood Transfus. 2021 Oct;37(4):576-585. doi: 10.1007/s12288-021-01409-w. Epub 2021 Feb 26. PMID: 34690454; PMCID: PMC8523604.

5. Karmakar T, Banerjee S, Brahma S, Dey D, Radhakrishnan V, Chandy M, Ghara N, Krishnan S, Mukherjee G, Mishra DK, Arora N. A Pilot Study to Determine the Utility of Automated Tissue Dissociator for Flowcytometry Based Evaluation of Hematolymphoid Tumor Tissue Biopsies. Indian J Hematol Blood Transfus. 2022 Apr;38(2):403-410. doi: 10.1007/s12288-021-01481-2. Epub 2021 Aug 15. PMID: 35496962; PMCID: PMC9001761.

1. Ghosh RD, Pattatheyil A, Roychoudhury S. Functional Landscape of Dysregulated MicroRNAs in Oral Squamous Cell Carcinoma: Clinical Implications. Front Oncol. 2020 May 12;10:619. doi: 10.3389/fonc.2020.00619. PMID: 32547936; PMCID: PMC7274490.

2. Mishra DK, Goel G, Arora N, Krishnan S, Bhattacharya S, Mathur P, Walia K, Chandy M. The importance of intra- and inter-institutional networks for capacity building in severe acute respiratory syndrome coronavirus 2 reverse transcription polymerase chain reaction services: experience from an oncology centre in eastern India. Indian J Med Microbiol. 2020 Jan-Mar;38(1):9-17. doi: 10.4103/ijmm.IJMM_20_255. PMID: 32719203; PMCID: PMC7706412.

1. Roy P, Islam R, Saha D, Gogoi M, Kumar Mishra D, Arora N, Parihar M, Krishnan S, Saha V. Efficacy and safety of a bortezomib and reduced-intensity cytarabine-based protocol, TMC ALLR1, for relapsed childhood ALL in India. Br J Haematol. 2019 Sep;186(6):861-865. doi: 10.1111/bjh.16005. Epub 2019 Jun 5. PMID: 31168836; PMCID: PMC6785345.

2. Parker C, Krishnan S, Hamadeh L, Irving JAE, Kuiper RP, Révész T, Hoogerbrugge P, Hancock J, Sutton R, Moorman AV, Saha V. Outcomes of patients with childhood B-cell precursor acute lymphoblastic leukaemia with late bone marrow relapses: long-term follow-up of the ALLR3 open-label randomised trial. Lancet Haematol. 2019 Apr;6(4):e204-e216. doi: 10.1016/S2352-3026(19)30003-1. Epub 2019 Feb 27. PMID: 30826273; PMCID: PMC6445853.

3. Biondi A, Cario G, De Lorenzo P, Castor A, Conter V, Leoni V, Gandemer V, Pieters R, Stary J, Escherich G, Campbell M, Attarbaschi A, Li CK, Vora A, Bradtke J, Saha V, Valsecchi MG, Schrappe M. Long-term follow up of pediatric Philadelphia positive acute lymphoblastic leukemia treated with the EsPhALL2004 study: high white blood cell count at diagnosis is the strongest prognostic factor. Haematologica. 2019 Jan;104(1):e13-e16. doi: 10.3324/haematol.2018.199422. Epub 2018 Sep 13. PMID: 30213832; PMCID: PMC6312020.

4. Gupta N, Pawar R, Banerjee S, Brahma S, Rath A, Shewale S, Parihar M, Singh M, Arun SR, Krishnan S, Bhatacharyya A, Das A, Kumar J, Bhave S, Radhakrishnan V, Nair R, Chandy M, Arora N, Mishra D. Spectrum and Immunophenotypic Profile of Acute Leukemia: A Tertiary Center Flow Cytometry Experience. Mediterr J Hematol Infect Dis. 2019 Mar 1;11(1):e2019017. doi: 10.4084/MJHID.2019.017. PMID: 30858955; PMCID: PMC6402547.

5. Gupta N, Parihar M, Banerjee S, Brahma S, Pawar R, Rath A, Shewale S, Singh M, Sasikumaran Nair Remani A, Krishnan S, Bhatacharyya A, Das A, Kumar J, Bhave S, Radhakrishnan V, Nair R, Chandy M, Mishra D, Arora N. FxCycle™ Based Ploidy Correlates with Cytogenetic Ploidy in B-Cell Acute Lymphoblastic Leukemia and Is Able to Detect the Aneuploid Minimal Residual Disease Clone. Cytometry B Clin Cytom. 2019 Sep;96(5):359-367. doi: 10.1002/cyto.b.21765. Epub 2019 Feb 4. PMID: 30715800.

6. Singh MK, Parihar M, Arora N, Mishra DK, Bhave SJ, Chandy M. Diagnosis of variant RARA translocation using standard dual-color dual-fusion PML/RARA FISH probes: An illustrative report. Hematol Oncol Stem Cell Ther. 2019 Mar;12(1):50-53. doi: 10.1016/j.hemonc.2016.12.003. Epub 2017 Feb 1. PMID: 28183680.

7. Singh MK, Sasikumaran Nair Remani A, Bhave SJ, Mishra DK, Arora N, Parihar M. Detection of BCR/PDGRFα Fusion Using Dual Colour Dual Fusion BCR/ABL1 Probe: An Illustrative Report. Indian J Hematol Blood Transfus. 2019 Jul;35(3):570-574. doi: 10.1007/s12288-019-01095-9. Epub 2019 Feb 18. PMID: 31388278; PMCID: PMC6646510.

1. Biondi A, Gandemer V, De Lorenzo P, Cario G, Campbell M, Castor A, Pieters R, Baruchel A, Vora A, Leoni V, Stary J, Escherich G, Li CK, Cazzaniga G, Cavé H, Bradtke J, Conter V, Saha V, Schrappe M, Grazia Valsecchi M. Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial. Lancet Haematol. 2018 Dec;5(12):e641-e652. doi: 10.1016/S2352-3026(18)30173-X. PMID: 30501871.

2. Mukhopadhyay A, Drew Y, Matheson E, Salehan M, Gentles L, Pachter JA, Curtin NJ. Evaluating the potential of kinase inhibitors to suppress DNA repair and sensitise ovarian cancer cells to PARP inhibitors. Biochem Pharmacol. 2019 Sep;167:125-132. doi: 10.1016/j.bcp.2018.10.011. Epub 2018 Oct 17. PMID: 30342021.

3. Satyavarapu EM, Das R, Mandal C, Mukhopadhyay A, Mandal C. Autophagy-independent induction of LC3B through oxidative stress reveals its non-canonical role in anoikis of ovarian cancer cells. Cell Death Dis. 2018 Sep 17;9(10):934. doi: 10.1038/s41419-018-0989-8. PMID: 30224639; PMCID: PMC6141567.

4. Mukhopadhyay A, Bizzarri N, Bradbury M, Sinha S, Bhaumik J, Helm CW. Metastatic Involvement of Lesser Sac in Advanced Epithelial Ovarian Cancer. Int J Gynecol Cancer. 2018 Feb;28(2):293-301. doi: 10.1097/IGC.0000000000001180. PMID: 29324540.

5. Parihar M, Singh MK, Islam R, Saha D, Mishra DK, Saha V, Krishnan S. A triple-probe FISH screening strategy for risk-stratified therapy of acute lymphoblastic leukaemia in low-resource settings. Pediatr Blood Cancer. 2018 Dec;65(12):e27366. doi: 10.1002/pbc.27366. Epub 2018 Aug 31. PMID: 30168245; PMCID: PMC6309222.

6. Mitra T, Prasad P, Mukherjee P, Chaudhuri SR, Chatterji U, Roy SS. Stemness and chemoresistance are imparted to the OC cells through TGFβ1 driven EMT. J Cell Biochem. 2018 Jul;119(7):5775-5787. doi: 10.1002/jcb.26753. Epub 2018 Mar 14. PMID: 29537103.

7. Cazzaniga G, De Lorenzo P, Alten J, Röttgers S, Hancock J, Saha V, Castor A, Madsen HO, Gandemer V, Cavé H, Leoni V, Köhler R, Ferrari GM, Bleckmann K, Pieters R, van der Velden V, Stary J, Zuna J, Escherich G, Stadt UZ, Aricò M, Conter V, Schrappe M, Valsecchi MG, Biondi A. Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies. Haematologica. 2018 Jan;103(1):107-115. doi: 10.3324/haematol.2017.176917. Epub 2017 Oct 27. PMID: 29079599; PMCID: PMC5777198.

8. Paul P, Rellinger EJ, Qiao J, Lee S, Volny N, Padmanabhan C, Romain CV, Mobley B, Correa H, Chung DH. Elevated TIMP-1 expression is associated with a prometastatic phenotype, disease relapse, and poor survival in neuroblastoma. Oncotarget. 2017 Jul 28;8(47):82609-82620. doi: 10.18632/oncotarget.19664. PMID: 29137288; PMCID: PMC5669914.

1. Qattan MY, Bakker EY, Rajendran R, Chen DW, Saha V, Liu J, Zeef L, Schwartz JM, Mutti L, Demonacos C, Krstic-Demonacos M. Differential regulation of cell death pathways by the microenvironment correlates with chemoresistance and survival in leukaemia. PLoS One. 2017 Jun 5;12(6):e0178606. doi: 10.1371/journal.pone.0178606. PMID: 28582465; PMCID: PMC5459454.

2. McGinn OJ, Krishnan S, Bourquin JP, Sapra P, Dempsey C, Saha V, Stern PL. Targeting the 5T4 oncofetal glycoprotein with an antibody drug conjugate (A1mcMMAF) improves survival in patient-derived xenograft models of acute lymphoblastic leukemia. Haematologica. 2017 Jun;102(6):1075-1084. doi: 10.3324/haematol.2016.158485. Epub 2017 Mar 24. PMID: 28341731; PMCID: PMC5451339.

3. Bhattacharya R, Mitra T, Ray Chaudhuri S, Roy SS. Mesenchymal splice isoform of CD44 (CD44s) promotes EMT/invasion and imparts stem-like properties to ovarian cancer cells. J Cell Biochem. 2018 Apr;119(4):3373-3383. doi: 10.1002/jcb.26504. Epub 2018 Jan 4. PMID: 29130517.

4. Johnson SM, Dempsey C, Parker C, Mironov A, Bradley H, Saha V. Acute lymphoblastic leukaemia cells produce large extracellular vesicles containing organelles and an active cytoskeleton. J Extracell Vesicles. 2017 Mar 10;6(1):1294339. doi: 10.1080/20013078.2017.1294339. PMID: 28386390; PMCID: PMC5373679.

5. Cuvertino S, Filiciotto G, Masurekar A, Saha V, Lacaud G, Kouskoff V. SOX7 promotes the maintenance and proliferation of B cell precursor acute lymphoblastic cells. Oncotarget. 2016 Jul 7;8(39):64974-64983. doi: 10.18632/oncotarget.10472. PMID: 29029405; PMCID: PMC5630305.

6. Frismantas V, Dobay MP, Rinaldi A, Tchinda J, Dunn SH, Kunz J, Richter-Pechanska P, Marovca B, Pail O, Jenni S, Diaz-Flores E, Chang BH, Brown TJ, Collins RH, Uhrig S, Balasubramanian GP, Bandapalli OR, Higi S, Eugster S, Voegeli P, Delorenzi M, Cario G, Loh ML, Schrappe M, Stanulla M, Kulozik AE, Muckenthaler MU, Saha V, Irving JA, Meisel R, Radimerski T, Von Stackelberg A, Eckert C, Tyner JW, Horvath P, Bornhauser BC, Bourquin JP. Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia. Blood. 2017 Mar 16;129(11):e26-e37. doi: 10.1182/blood-2016-09-738070. Epub 2017 Jan 25. PMID: 28122742; PMCID: PMC5356455.

7. Pawar RN, Banerjee S, Bramha S, Krishnan S, Bhattacharya A, Saha V, Chakrapani A, Bhave S, Chandy M, Nair R, Parihar M, Arora N, Mishra DK. Mixed-phenotypic acute leukemia series from tertiary care center. Indian J Pathol Microbiol. 2017 Jan-Mar;60(1):43-49. doi: 10.4103/0377-4929.200057. PMID: 28195090.

8. Das A, Ray R, Sinha T, Gogoi M, Krishnan S, Bhattacharyya A. Undernutrition in Pediatric Malignancy. Indian J Pediatr. 2017 Nov;84(11):875-876. doi: 10.1007/s12098-017-2399-9. Epub 2017 Jun 17. PMID: 28623457.

9. Tan KA, Lum SH, Yahya A, Krishnan S, Jalaludin MY, Lee WS. Prevalence of growth and endocrine disorders in Malaysian children with transfusion-dependent thalassaemia. Singapore Med J. 2019 Jun;60(6):303-308. doi: 10.11622/smedj.2018155. Epub 2018 Dec 17. PMID: 30556093; PMCID: PMC6595058.

1. Johnson SM, Dempsey C, Chadwick A, Harrison S, Liu J, Di Y, McGinn OJ, Fiorillo M, Sotgia F, Lisanti MP, Parihar M, Krishnan S, Saha V. Metabolic reprogramming of bone marrow stromal cells by leukemic extracellular vesicles in acute lymphoblastic leukemia. Blood. 2016 Jul 21;128(3):453-6. doi: 10.1182/blood-2015-12-688051. Epub 2016 Apr 20. PMID: 27099150.

2. Lum SH, Choong SS, Krishnan S, Mohamed Z, Ariffin H. GATA1 mutations in a cohort of Malaysian children with Down syndrome-associated myeloid disorder. Singapore Med J. 2016 Jun;57(6):320-4. doi: 10.11622/smedj.2016106. PMID: 27353457; PMCID: PMC4971451.

1. Liu J, Masurekar A, Johnson S, Chakraborty S, Griffiths J, Smith D, Alexander S, Dempsey C, Parker C, Harrison S, Li Y, Miller C, Di Y, Ghosh Z, Krishnan S, Saha V. Stromal cell-mediated mitochondrial redox adaptation regulates drug resistance in childhood acute lymphoblastic leukemia. Oncotarget. 2015 Dec 15;6(40):43048-64. doi: 10.18632/oncotarget.5528. PMID: 26474278; PMCID: PMC4767490.

2. Datta SS, Reddy M, Basu S, Krishnan S. Blood Group Discrepancy-First Sign of Autoimmune Hemolytic Anemia after Hematopoietic Stem Cell Transplantation in a Child. Indian J Hematol Blood Transfus. 2016 Jun;32(Suppl 1):211-3. doi: 10.1007/s12288-015-0630-2. Epub 2015 Dec 19. PMID: 27408394; PMCID: PMC4925543.

1. Ariffin H, Hainaut P, Puzio-Kuter A, Choong SS, Chan AS, Tolkunov D, Rajagopal G, Kang W, Lim LL, Krishnan S, Chen KS, Achatz MI, Karsa M, Shamsani J, Levine AJ, Chan CS. Whole-genome sequencing analysis of phenotypic heterogeneity and anticipation in Li-Fraumeni cancer predisposition syndrome. Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):15497-501. doi: 10.1073/pnas.1417322111. Epub 2014 Oct 13. PMID: 25313051; PMCID: PMC4217424.